Andy Cooper
Showing 1–2 of 2 transcripts.
- The Economist16 min
How AI is revolutionising science
Bear, Andy Davis, Alex Zarankov, Emily Shuckborough, Adi Rakhoum, Andy Cooper, Alok Jha
Generative AI is revolutionizing scientific discovery by accelerating drug development, exemplified by Insilico Medicine's rapid creation of an IPF treatment, while simultaneously advancing climate modeling and animal communication research through sophisticated pattern recognition. Autonomous robotic labs and tools like AlphaFold are further democratizing innovation by processing vast datasets and conducting thousands of experiments, though this surge in capability has triggered significant concerns regarding research integrity and AI-generated fraud. As investment flows into these multidisciplinary fields, the industry faces critical challenges in establishing robust data standards and regulations to ensure these tools achieve the projected "golden age" of discovery without compromising scientific validity.
- Milken Institute1h 1m
Impact Investing: The Art of the Deal
Dave Chen, N. Lee, Sari Miller, Eitan Stibbe, Martha Minowski, Ann Coopermann, Chip, Andy Cooper
A panel of global investment leaders from Equilibrium Capital Group, Impact Investment Exchange, LeapFrog, and Vital Capital convened to define impact investing as a practice where intentional social and environmental outcomes are non-negotiable components of the investment thesis alongside market-rate or preservation returns. The discussion detailed practical execution strategies, ranging from complex financing structures like convertible notes and tax equity flips to rigorous measurement frameworks such as GEARS that rejected 40% of opportunities due to social and environmental risks. By highlighting specific case studies in micro-insurance, African agro-industrial centers, and US real estate, the panel demonstrated how practitioners mitigate mission drift and generate sustainable alpha through deep community integration and strategic capital stacking.